ARTV Competitors & Alternatives
Compare Artiva Biotherapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
ARTV
Main Stock$9.61
Tradestie Score
57
Market Cap
$71.32M
Revenue Growth
-1.0%
Analyst Upside
+272.5%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$38.72
|
$505.12M | 2.0 | 54 | Compare |
|
RGNX
REGENXBIO Inc.
|
$13.28
|
$493.52M | - | 56 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$97.58
|
$492.21M | - | 52 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$43.00
|
$474.20M | 27.1 | 59 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$11.62
|
$468.01M | - | 52 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$24.21
|
$463.20M | - | 59 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$10.84
|
$457.09M | - | 54 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$6.04
|
$454.29M | - | 58 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$18.95
|
$448.32M | - | 45 | Compare |
More ARTV Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2836)
234 stocks in this industry